{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T14:34:46Z","timestamp":1779201286695,"version":"3.51.4"},"reference-count":47,"publisher":"Japanese Society for the Study of Xenobiotics","issue":"2","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2010]]},"DOI":"10.2133\/dmpk.25.190","type":"journal-article","created":{"date-parts":[[2010,5,7]],"date-time":"2010-05-07T06:06:43Z","timestamp":1273212403000},"page":"190-199","source":"Crossref","is-referenced-by-count":71,"title":["Hepatitis C Virus-related Cirrhosis is a Major Determinant of the Expression Levels of Hepatic Drug Transporters"],"prefix":"10.2133","volume":"25","author":[{"given":"Ken","family":"Ogasawara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Terada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiya","family":"Katsura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etsuro","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iwao","family":"Ikai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Yamaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichi","family":"Inui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"900","reference":[{"key":"10.2133\/dmpk.25.190_bb0005","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0169-409X(02)00173-4","article-title":"Drug transport proteins in the liver","volume":"55","author":"Faber","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.2133\/dmpk.25.190_bb0010","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1023\/B:PHAM.0000026420.79421.8f","article-title":"The complexities of hepatic drug transport: current knowledge and emerging concepts","volume":"21","author":"Chandra","year":"2004","journal-title":"Pharm. Res."},{"key":"10.2133\/dmpk.25.190_bb0015","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.103.053298","article-title":"Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3)","volume":"308","author":"Jonker","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.2133\/dmpk.25.190_bb0020","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1254\/jphs.CRJ06006X","article-title":"Organic anion transporter family: current knowledge","volume":"100","author":"Anzai","year":"2006","journal-title":"J. Pharmacol. Sci."},{"key":"10.2133\/dmpk.25.190_bb0025","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00424-003-1168-y","article-title":"Organic anion transporting polypeptides of the OATP\/SLC21 family: phylogenetic classification as OATP\/SLCO superfamily, new nomenclature and molecular\/functional properties","volume":"447","author":"Hagenbuch","year":"2004","journal-title":"PJUgers. Arch."},{"key":"10.2133\/dmpk.25.190_bb0030","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2133\/dmpk.19.171","article-title":"The organic anion transporter (OATP' family","volume":"19","author":"Mikkaichi","year":"2004","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.2133\/dmpk.25.190_bb0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(02)00169-2","article-title":"Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview","volume":"55","author":"Schinkel","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.2133\/dmpk.25.190_bb0040","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.taap.2004.10.012","article-title":"Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense","volume":"204","author":"Leslie","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.2133\/dmpk.25.190_bb0045","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00424-006-0054-9","article-title":"Multidrug resistance-associated proteins 3, 4, and 5","volume":"453","author":"Borst","year":"2007","journal-title":"PflUgers. Arch."},{"key":"10.2133\/dmpk.25.190_bb0050","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10555-007-9039-1","article-title":"Physiological and pharmacological functions of Mrp2, Mrp3 and Mrp4 as determined from recent studies on gene-disrupted mice","volume":"26","author":"Kruh","year":"2007","journal-title":"Cancer Metastasis. Rev."},{"key":"10.2133\/dmpk.25.190_bb0055","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s11095-006-9159-2","article-title":"Influence of drug transporter polymorphisms on pravastatin pharmacokinetics in humans","volume":"24","author":"Kivisto","year":"2007","journal-title":"Pharm. Res."},{"key":"10.2133\/dmpk.25.190_bb0060","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMoa0801936","article-title":"SLCO1B1 variants and statin-induced myopathy-a genomewide study","volume":"359","author":"Link","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.2133\/dmpk.25.190_bb0065","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1172\/JCI30558","article-title":"Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action","volume":"117","author":"Shu","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.2133\/dmpk.25.190_bb0070","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/sj.clpt.6100275","article-title":"Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics","volume":"83","author":"Shu","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.2133\/dmpk.25.190_bb0075","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00424-006-0109-y","article-title":"The apical conjugate efflux pump ABCC2 (MRP2)","volume":"453","author":"Nies","year":"2007","journal-title":"PJugers. Arch."},{"key":"10.2133\/dmpk.25.190_bb0080","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1023\/A:1016086003070","article-title":"Carrier-mediated intestinal transport of drugs","volume":"13","author":"Tsuji","year":"1996","journal-title":"Pharm. Res."},{"key":"10.2133\/dmpk.25.190_bb0085","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1046\/j.1523-1755.2000.00251.x","article-title":"Cellular and molecular aspects of drug transport in the kidney","volume":"58","author":"Inui","year":"2000","journal-title":"Kidney Int."},{"key":"10.2133\/dmpk.25.190_bb0090","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1067\/mcp.2001.115142","article-title":"Pharmacokinetic and prognostic significance of intestinal MDR1 expression in recipients of living-donor liver transplantation","volume":"69","author":"Hashida","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.2133\/dmpk.25.190_bb0095","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1023\/B:PHAM.0000012153.71993.cb","article-title":"Expression levels of renal organic anion transporters (OATs) and their correlation with anionic drug excretion in patients with renal diseases","volume":"21","author":"Sakurai","year":"2004","journal-title":"Pharm. Res."},{"key":"10.2133\/dmpk.25.190_bb0100","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1007\/s11095-005-8383-5","article-title":"Pharmacokinetic significance of renal OAT3 (SLC22A8) for anionic drug elimination in patients with mesangial proliferative glomerulonephritis","volume":"22","author":"Sakurai","year":"2005","journal-title":"Pharm. Res."},{"key":"10.2133\/dmpk.25.190_bb0105","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.bcp.2005.09.027","article-title":"Expression profiles of various transporters for oligopeptides, amino acids and organic ions along the human digestive tract","volume":"70","author":"Terada","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.2133\/dmpk.25.190_bb0110","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.bcp.2006.10.010","article-title":"Gene expression and regulation of drug transporters in the intestine and kidney","volume":"73","author":"Terada","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.2133\/dmpk.25.190_bb0115","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1053\/jhep.2001.22646","article-title":"Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases","volume":"33","author":"Zollner","year":"2001","journal-title":"Hepatology"},{"key":"10.2133\/dmpk.25.190_bb0120","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0168-8278(03)00096-5","article-title":"Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis","volume":"38","author":"Zollner","year":"2003","journal-title":"J. Hepatol."},{"key":"10.2133\/dmpk.25.190_bb0125","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1111\/j.1572-0241.2001.05339.x","article-title":"The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function","volume":"96","author":"Shoda","year":"2001","journal-title":"Am. J. Gastroenterol."},{"key":"10.2133\/dmpk.25.190_bb0130","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1681\/ASN.V134866","article-title":"Gene expression levels and immunolocalization of organic ion transporters in the human kidney","volume":"13","author":"Motohashi","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.2133\/dmpk.25.190_bb0135","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1681\/ASN.2006030205","article-title":"Identification and functional characterization of a new human kidney-specific H + \/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2","volume":"17","author":"Masuda","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.2133\/dmpk.25.190_bb0140","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s10038-003-0105-4","article-title":"Common single nucleotide polymorphisms of the MDR1 gene have no influence on its mRNA expression level of normal kidney cortex and renal cell carcinoma in Japanese nephrectomized patients","volume":"49","author":"Uwai","year":"2004","journal-title":"J. Hum. Genet."},{"key":"10.2133\/dmpk.25.190_bb0145","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/FPC.0b013e32832fabd3","article-title":"Impact of regulatory polymorphisms in organic anion transporter genes in the human liver","volume":"19","author":"Aoki","year":"2009","journal-title":"Pharmacogent. Genomics"},{"key":"10.2133\/dmpk.25.190_bb0150","doi-asserted-by":"crossref","first-page":"452","DOI":"10.2133\/dmpk.20.452","article-title":"Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies","volume":"20","author":"Nishimura","year":"2005","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.2133\/dmpk.25.190_bb0155","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1124\/dmd.107.014902","article-title":"Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines","volume":"35","author":"Hilgendorf","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.2133\/dmpk.25.190_bb0160","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.tips.2008.01.006","article-title":"Multidrug resistance protein 4 (MRP4\/ABCC4): a versatile efflux transporter for drugs and signalling molecules","volume":"29","author":"Russel","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.2133\/dmpk.25.190_bb0165","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/jhep.2003.50331","article-title":"Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane","volume":"38","author":"Rius","year":"2003","journal-title":"Hepatology"},{"key":"10.2133\/dmpk.25.190_bb0170","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/sj.tpj.6500451","article-title":"Variability in human hepatic MRP4 expression: influence of cholestasis and genotype","volume":"8","author":"Gradhand","year":"2008","journal-title":"Pharmacogenomics J."},{"key":"10.2133\/dmpk.25.190_bb0175","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0016-5085(03)01068-0","article-title":"Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice","volume":"125","author":"Wagner","year":"2003","journal-title":"Gastroenterology"},{"key":"10.2133\/dmpk.25.190_bb0180","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jhep.2003.12.001","article-title":"Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat","volume":"40","author":"Denk","year":"2004","journal-title":"J. Hepatol."},{"key":"10.2133\/dmpk.25.190_bb0185","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/hep.21158","article-title":"Mrp4 \u2014\/\u2014 mice have an impaired cytoprotective response in obstructive cholestasis","volume":"43","author":"Mennone","year":"2006","journal-title":"Hepatology"},{"key":"10.2133\/dmpk.25.190_bb0190","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/hep.20682","article-title":"Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis","volume":"41","author":"Keitel","year":"2005","journal-title":"Hepatology"},{"key":"10.2133\/dmpk.25.190_bb0195","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1478-3231.2007.01506.x","article-title":"Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis","volume":"27","author":"Zollner","year":"2007","journal-title":"Liver Int."},{"key":"10.2133\/dmpk.25.190_bb0200","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1124\/dmd.107.016170","article-title":"Induction of hepatobiliary efflux transporters in acetaminophen-induced acute liver failure cases","volume":"35","author":"Barnes","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.2133\/dmpk.25.190_bb0205","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0168-8278(01)00216-1","article-title":"Decreased expression of an ATP-binding cassette transporter, MRP2, in human livers with hepatitis C virus infection","volume":"35","author":"Hinoshita","year":"2001","journal-title":"J. Hepatol."},{"key":"10.2133\/dmpk.25.190_bb0210","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1124\/dmd.107.020073","volume":"36","author":"Nakai","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.2133\/dmpk.25.190_bb0215","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.freeradbiomed.2007.05.036","article-title":"Redox regulation of hepatitis C in nonalcoholic and alcoholic liver","volume":"43","author":"Seronello","year":"2007","journal-title":"Free. Radic. Biol. Med."},{"key":"10.2133\/dmpk.25.190_bb0220","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1002\/hep.22269","article-title":"Hepatitis C virus infection: molecular pathways to metabolic syndrome","volume":"47","author":"Sheikh","year":"2008","journal-title":"Hepatology"},{"key":"10.2133\/dmpk.25.190_bb0225","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1124\/dmd.108.023630","article-title":"Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-\u03b1 or interleukin-6","volume":"37","author":"Vee","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.2133\/dmpk.25.190_bb0230","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1099\/vir.0.014340-0","article-title":"Activation of transcription factor Nrf2 by hepatitis C virus induces cell survival pathway","volume":"91","author":"Burdette","year":"2010","journal-title":"J. Gen. Virol"},{"key":"10.2133\/dmpk.25.190_bb0235","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1002\/hep.21831","article-title":"Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway","volume":"46","author":"Maher","year":"2007","journal-title":"Hepatology"}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1347436715300215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1347436715300215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T10:18:03Z","timestamp":1635329883000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436715300215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010]]}},"alternative-id":["S1347436715300215"],"URL":"https:\/\/doi.org\/10.2133\/dmpk.25.190","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}